| CAS登錄號 | 中文名 | 英文名 | 分子結構式 | 分子式 | 詳情 | 供應商 |
| 50516-43-3 | 1H-Isoindol-1-one,2,3-dihydro-3-[2-hydroxy-3-[(1-methylethyl)amino]propoxy]-2-phenyl-; Nofecainide |  | C20H24N2O3 | 詳情 | 供應商 | |
| 50516-42-2 | 1H-Isoindol-1-one,2,3-dihydro-3-(2-oxiranylmethoxy)-2-phenyl-; 1H-Isoindol-1-one,2,3-dihydro-3-(oxiranylmethoxy)-2-phenyl- (9CI) |  | C17H15NO3 | 詳情 | 供應商 | |
| 14074-90-9 | 1H-Isoindol-1-one,2,3-dihydro-2-[4-(1-pyrrolidinyl)-2-butyn-1-yl]-, (2E)-2-butenedioate (1:1); 1H-Isoindol-1-one,2,3-dihydro-2-[4-(1-pyrrolidinyl)-2-butynyl]-, (2E)-2-butenedioate (1:1) (9CI); 1H-Isoindol-1-one, 2,3-dihydro-2-[4-(1-pyrrolidinyl)-2-butynyl]-,(E)-2-butenedioate (1:1); Phthalimidine, 2-[4-(1-pyrrolidinyl)-2-butynyl]-,fumarate (1:1) (8CI) |  | C20H22N2O5 | 詳情 | 供應商 | |
| 26486-93-1 | 1H-Isoindol-1-one,2,3-dihydro-3-hydroxy-; Phthalimidine,3-hydroxy- (6CI,8CI); 3-Hydroxy-1-isoindolinone; 3-Hydroxyphthalimidine |  | C8H7NO2 | 詳情 | 供應商 | |
| 5334-06-5 | 1H-Isoindol-1-one,2,3-dihydro-2-(2-hydroxyethyl)-; Phthalimidine,2-(2-hydroxyethyl)- (6CI,8CI); 2-(2-Hydroxyethyl)-1-isoindolinone; N-(2-Hydroxyethyl)phthalimidine; NSC 2381 |  | C10H11NO2 | 詳情 | 供應商 | |
| 5415-18-9 | 1H-Isoindol-1-one,2,3-dihydro-2-nitroso-; Phthalimidine,2-nitroso- (8CI); N-Nitrosophthalimidine; NSC 11209; NSC 61823 |  | C8H6N2O2 | 詳情 | 供應商 | |
| 3532-66-9 | 1H-Isoindol-1-one,2,3-dihydro-3-hydroxy-2-(4-nitrophenyl)-3-phenyl-; Phthalimidine,3-hydroxy-2-(p-nitrophenyl)-3-phenyl- (7CI); NSC 69361 |  | C20H14N2O4 | 詳情 | 供應商 | |
| 69582-32-7 | 1H-Isoindol-1-one,3-(4-chlorophenyl)-3-(dimethylamino)-2,3-dihydro-2-methyl-; 1H-Isoindol-1-one, 3-(4-chlorophenyl)-3-(dimethylamino) -2,3-dihydro-2-methyl- |  | C17H17ClN2O | 詳情 | 供應商 | |
| 3532-65-8 | 1H-Isoindol-1-one,2-(3-aminophenyl)-2,3-dihydro-3-hydroxy-3-phenyl-; Phthalimidine,2-(m-aminophenyl)-3-hydroxy-3-phenyl- (7CI); NSC 69367 |  | C20H16N2O2 | 詳情 | 供應商 | |
| 103255-62-5 | 1H-Isoindol-1-one,2,3-dihydro-2-(4-methoxyphenyl)-5-nitro-3-[2-oxo-2-(4-oxo-1-piperidinyl)ethyl]-; 4-Piperidinone,1-[[2,3-dihydro-2-(4-methoxyphenyl)-6-nitro-3-oxo-1H-isoindol-1-yl]acetyl]-(9CI) |  | C22H21N3O6 | 詳情 | 供應商 | |
| 23659-69-0 | 1H-Isoindol-1-one,2,3-dihydro-2,3,3-triphenyl-; Phthalimidine,2,3,3-triphenyl- (8CI); 2,3,3-Triphenylphthalimidine; NSC 110411 |  | C26H19NO | 詳情 | 供應商 | |
| 404859-21-8 | 1H-Isoindol-1-one,3-methyl-; 1H-Isoindol-1-one, 3-methyl- (9CI) |  | C9H7NO | 詳情 | 供應商 | |
| 3532-72-7 | 1H-Isoindol-1-one,2,3-dihydro-3-hydroxy-2-(3-methylphenyl)-3-phenyl-; Phthalimidine,3-hydroxy-3-phenyl-2-m-tolyl- (7CI); NSC 67327 |  | C21H17NO2 | 詳情 | 供應商 | |
| 480-91-1 | 異吲哚啉-1-酮 | 1H-Isoindol-1-one,2,3-dihydro-; Phthalimidine(6CI,7CI,8CI); 1-Isoindolinone; 1-Oxodihydroisoindole; 1-Oxoisoindoline; 2,3-Dihydro-1H-Isoindol-1-one; 2,3-Dihydroisoindol-1-one; 3,4-Benzopyrrolidone; Isoindolinone; NSC 3689 |  | C8H7NO | 詳情 | 供應商 |
| 4778-84-1 | 1H-Isoindol-1-one,2,3-dihydro-2-(4-methylphenyl)-; Phthalimidine,2-p-tolyl- (6CI,7CI,8CI) |  | C15H13NO | 詳情 | 供應商 | |
| 65399-00-0 | 1H-Isoindol-1-one,2,3-dihydro-2-(1-methylethyl)-; Phthalimidine,2-isopropyl- (7CI) |  | C11H13NO | 詳情 | 供應商 | |
| 133737-32-3 | 1H-Isoindol-1-one,2-(7-chloro-1,8-naphthyridin-2-yl)-2,3-dihydro-3-(5-methyl-2-oxohexyl)-, (+)-; (+)-RP59037; IP 456; Pagoclone; RP 62955 |  | C23H22ClN3O2 | 詳情 | 供應商 | |
| 3532-42-1 | 1H-Isoindol-1-one,2,3-dihydro-3-hydroxy-2-(4-methyl-2-pyridinyl)-3-phenyl-; Phthalimidine, 3-hydroxy-2-(4-methyl-2-pyridyl)-3-phenyl-(7CI); NSC 69356 |  | C20H16N2O2 | 詳情 | 供應商 | |
| 143114-82-3 | 1H-Isoindol-1-one,2,3-dihydro-2-(2-hydroxyethyl)-4-methoxy-5-methyl-6-[(3-methyl-2-buten-1-yl)oxy]-; 1H-Isoindol-1-one,2,3-dihydro-2-(2-hydroxyethyl)-4-methoxy-5-methyl-6-[(3-methyl-2-butenyl)oxy]-(9CI); Porritoxin |  | C17H23NO4 | 詳情 | 供應商 | |
| 133737-48-1 | Pagoclone; PAGOCLONE; 1H-Isoindol-1-one, 2-(7-chloro-1,8-naphthyridin-2-yl)-2,3-dihydro-3-(5-methyl-2-oxohexyl)-; 2-(7-Chloro-2-naphthyridin-1,8-yl)-3-(5-methyl-2-oxohexyl)isoindolin-1-one |  | C23H22ClN3O2 | 詳情 | 供應商 | |